Also known as Plasma Cell Myeloma, Plasma Cell Neoplasms, Kahler Disease, and Myelomatosis
Multiple myeloma(from Greek myelo-, bone marrow), also known as plasma cell myeloma or Kahler's disease (after Otto Kahler), is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. Most cases of myeloma also feature the production of a paraprotein—an abnormal antibody which can cause kidney problems. Bone lesions and hypercalcemia (high calcium levels) are also often encountered.Source: Wikipedia
Within all the people who go to their doctor with multiple myeloma, 37% report having weakness, 29% report having fatigue, and 9% report having problems with movement. The symptoms that are highly suggestive of multiple myeloma are stiffness all over and hip lump or mass, although you may still have multiple myeloma without those symptoms.
Patients with multiple myeloma often receive hematologic tests, complete blood count, glucose measurement, electrolytes panel, complete physical skin exam performed (ml), hemoglobin a1c measurement, biopsy and examination of foot .
The most commonly prescribed drugs for patients with multiple myeloma include bortezomib (velcade), zoledronic acid (reclast), dexamethasone topical product, lenalidomide (revlimid), dexamethasone, oxycodone, pamidronate, acyclovir, thalidomide, epoetin alfa (procrit), darbepoetin alfa (aranesp), melphalan and heparin .
|Zoledronic Acid (Reclast)||$835|
|Dexamethasone Topical Product|
|Epoetin Alfa (Procrit)||$804|
|Darbepoetin Alfa (Aranesp)||$1004|
Groups of people at highest risk for multiple myeloma include age 75+ years age 60-74 years. On the other hand, age 5-14 years, age 1-4 years, age 15-29 years, and age < 1 years almost never get multiple myeloma.